One-component nanomedicine

Journal of Controlled Release

Volumn 219, Issue , 2015, Pages 383-395

  Su, Hao ^a   Koo, Jin Mo ^a   Cui, Honggang ^a,b,c  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Drug delivery; Nanomedicine

Indexed keywords

DISEASES; DRUG DELIVERY; FUNCTIONAL POLYMERS;

CHEMICAL SUBSTANCE; FABRICATION STRATEGIES; MOLECULAR ENGINEERING; MULTI-COMPONENT SYSTEMS; NANO-SCALE OBJECTS; PHYSICOCHEMICAL FEATURES; PHYSICOCHEMICAL PROPERTY; THERAPEUTIC AGENTS;

MEDICAL NANOTECHNOLOGY;

ADENOSINE; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; ASPARAGINASE MACROGOL; CAMPTOTHECIN; CHLORAMBUCIL; CISPLATIN; DEOXYCYTIDINE; DOXORUBICIN; DOXORUBICIN DERIVATIVE; GEMCITABINE; IRINOTECAN; METHOTREXATE; MONOCLONAL ANTIBODY; NANOCARRIER; NANOMATERIAL; NANOPARTICLE; NUCLEOSIDE ANALOG; PACLITAXEL; PEGADEMASE; PEGFILGRASTIM; PEGINTERFERON ALPHA2A; POLYMER; POLYPEPTIDE; PRODRUG; PROTEIN; RITUXIMAB; SQUALENE; TRASTUZUMAB EMTANSINE; UNINDEXED DRUG;

ARTICLE; ATOM TRANSFER RADICAL POLYMERIZATION; CANCER CHEMOTHERAPY; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; DRUG RELEASE; DRUG SOLUBILITY; HUMAN; IC50; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR MODEL; NANOFABRICATION; NANOMEDICINE; NANOPRECIPITATION; NEOPLASM; NONHUMAN; ONE COMPONENT NANOMEDICINE; PHYSICAL CHEMISTRY; PRECIPITATION; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; ANIMAL;

ANIMALS; DRUG DELIVERY SYSTEMS; NANOMEDICINE; NANOSTRUCTURES;

EID: 84947252300     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.09.056     Document Type: Article

References (189)

1. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discov. 9 2010 615 627
2. P.C. Zhang, A.G. Cheetham, Y.A. Lin, and H. Cui Self-assembled Tat nanofibers as effective drug carrier and transporter ACS Nano 7 2013 5965 5977
3. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160
4. J.W. Park Liposome-based drug delivery in breast cancer treatment Breast Cancer Res. 4 2002 93 97
5. Y. Kaneda Virosomes: evolution of the liposome as a targeted drug delivery system Adv. Drug Deliv. Rev. 43 2000 197 205
6. L. Brannon-Peppas, and J.O. Blanchette Nanoparticle and targeted systems for cancer therapy Adv. Drug Deliv. Rev. 64 2012 206 212
7. I. Brigger, C. Dubernet, and P. Couvreur Nanoparticles in cancer therapy and diagnosis Adv. Drug Deliv. Rev. 64 2012 24 36
8. R. Langer Drug delivery and targeting Nature 392 1998 5 10
9. E.M. Pridgen, R. Langer, and O.C. Farokhzad Biodegradable, polymeric nanoparticle delivery systems for cancer therapy Nanomedicine (London) 2 2007 669 680
10. K.S. Soppimath, T.M. Aminabhavi, A.R. Kulkarni, and W.E. Rudzinski Biodegradable polymeric nanoparticles as drug delivery devices J. Control. Release 70 2001 1 20
11. C.C. Lee, J.A. MacKay, J.M.J. Frechet, and F.C. Szoka Designing dendrimers for biological applications Nat. Biotechnol. 23 2005 1517 1526
12. I.J. Majoros, A. Myc, T. Thomas, C.B. Mehta, and J.R. Baker PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality Biomacromolecules 7 2006 572 579
13. T.D. McCarthy, P. Karellas, S.A. Henderson, M. Giannis, D.F. O'Keefe, G. Heery, J.R.A. Paull, B.R. Matthews, and G. Holan Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention Mol. Pharm. 2 2005 312 318
14. M. Najlah, and A. D'Emanuele Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery Curr. Opin. Drug Discov. 10 2007 756 767
15. J. Yu, W. Ha, J. Chen, and Y.P. Shi pH-responsive supramolecular hydrogels for codelivery of hydrophobic and hydrophilic anticancer drugs RSC Adv. 4 2014 58982 58989
16. M. Johannsen, U. Gneveckow, L. Eckelt, A. Feussner, N. Waldofner, R. Scholz, S. Deger, P. Wust, S.A. Loening, and A. Jordan Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique Int. J. Hyperth. 21 2005 637 647
17. J.R. McCarthy, and R. Weissleder Multifunctional magnetic nanoparticles for targeted imaging and therapy Adv. Drug Deliv. Rev. 60 2008 1241 1251
18. T. Murakami, and K. Tsuchida Recent advances in inorganic nanoparticle-based drug delivery systems Mini-Rev. Med. Chem. 8 2008 175 183
19. W.Y. Kim, J.T. Xiao, and E.L. Chaikof Recombinant amphiphilic protein micelles for drug delivery Langmuir 27 2011 14329 14334
20. R. Marullo, M. Kastantin, L.B. Drews, and M. Tirrell Peptide contour length determines equilibrium secondary structure in protein-analogous micelles Biopolymers 99 2013 573 581
21. M. Tirrell Modular materials by self-assembly AIChE J. 51 2005 2386 2390
22. A. Trent, R. Marullo, B. Lin, M. Black, and M. Tirrell Structural properties of soluble peptide amphiphile micelles Soft Matter 7 2011 9572 9582
23. E.K. Chow, X.Q. Zhang, M. Chen, R. Lam, E. Robinson, H.J. Huang, D. Schaffer, E. Osawa, A. Goga, and D. Ho Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment Sci. Transl. Med. 3 2011
24. R. Lam, and D. Ho Nanodiamonds as vehicles for systemic and localized drug delivery Expert Opin. Drug Deliv. 6 2009 883 895
25. V.N. Mochalin, O. Shenderova, D. Ho, and Y. Gogotsi The properties and applications of nanodiamonds Nat. Nanotechnol. 7 2012 11 23
26. X.Q. Zhang, R. Lam, X.Y. Xu, E.K. Chow, H.J. Kim, and D. Ho Multimodal nanodiamond drug delivery carriers for selective targeting, imaging, and enhanced chemotherapeutic efficacy Adv. Mater. 23 2011 4770 4775
27. Y. Zhu, J. Li, W.X. Li, Y. Zhang, X.F. Yang, N. Chen, Y.H. Sun, Y. Zhao, C.H. Fan, and Q. Huang The biocompatibility of nanodiamonds and their application in drug delivery systems Theranostics 2 2012 302 312
28. E. Fernandes, J.A. Ferreira, A. Peixoto, L. Lima, S. Barroso, B. Sarmento, and L.L. Santos New trends in guided nanotherapies for digestive cancers: a systematic review J. Control. Release 209 2015 288 307
29. M. Harries, P. Ellis, and P. Harper Nanoparticle albumin-bound paclitaxel for metastatic breast cancer J. Clin. Oncol. 23 2005 7768 7771
30. F. Kratz Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles J. Control. Release 132 2008 171 183
31. K.J. Cho, X. Wang, S.M. Nie, Z. Chen, and D.M. Shin Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 14 2008 1310 1316
32. H. Lee, A.K.R. Lytton-Jean, Y. Chen, K.T. Love, A.I. Park, E.D. Karagiannis, A. Sehgal, W. Querbes, C.S. Zurenko, M. Jayaraman, C.G. Peng, K. Charisse, A. Borodovsky, M. Manoharan, J.S. Donahoe, J. Truelove, M. Nahrendorf, R. Langer, and D.G. Anderson Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery Nat. Nanotechnol. 7 2012 389 393
33. E. Ruoslahti, S.N. Bhatia, and M.J. Sailor Targeting of drugs and nanoparticles to tumors J. Cell Biol. 188 2010 759 768
34. M. Ferrari Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 5 2005 161 171
35. C.W. Su, C.S. Chiang, W.M. Li, S.H. Hu, and S.Y. Chen Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment Nanomedicine (London) 9 2014 1499 1515
36. R. Duncan, and R. Gaspar Nanomedicine(s) under the microscope Mol. Pharm. 8 2011 2101 2141
37. P. Grodzinski, and D. Farrell Future opportunities in cancer nanotechnology-NCI strategic workshop report Cancer Res. 74 2014 1307 1310
38. N. Kamaly, Z.Y. Xiao, P.M. Valencia, A.F. Radovic-Moreno, and O.C. Farokhzad Targeted polymeric therapeutic nanoparticles: design, development and clinical translation Chem. Soc. Rev. 41 2012 2971 3010
39. U. Prabhakar, H. Maeda, R.K. Jain, E.M. Sevick-Muraca, W. Zamboni, O.C. Farokhzad, S.T. Barry, A. Gabizon, P. Grodzinski, and D.C. Blakey Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology Cancer Res. 73 2013 2412 2417
40. V.J. Venditto, and F.C. Szoka Cancer nanomedicines: so many papers and so few drugs! Adv. Drug Deliv. Rev. 65 2013 80 88
41. R. Lin, and H.G. Cui Supramolecular nanostructures as drug carriers Curr. Opin. Chem. Eng. 7 2015 75 83
42. J.A. MacKay, M.N. Chen, J.R. McDaniel, W.G. Liu, A.J. Simnick, and A. Chilkoti Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection Nat. Mater. 8 2009 993 999
43. D. Desmaele, R. Gref, and P. Couvreur Squalenoylation: a generic platform for nanoparticular drug delivery J. Control. Release 161 2012 609 618
44. K. Kataoka, A. Harada, and Y. Nagasaki Block copolymer micelles for drug delivery: design, characterization and biological significance Adv. Drug Deliv. Rev. 64 2012 37 48
45. A.G. Cheetham, P.C. Zhang, Y.A. Lin, L.L. Lock, and H.G. Cui Supramolecular nanostructures formed by anticancer drug assembly J. Am. Chem. Soc. 135 2013 2907 2910
46. V. Delplace, P. Couvreur, and J. Nicolas Recent trends in the design of anticancer polymer prodrug nanocarriers Polym. Chem. (UK) 5 2014 1529 1544
47. K. Kataoka, G.S. Kwon, M. Yokoyama, T. Okano, and Y. Sakurai Block-copolymer micelles as vehicles for drug delivery J. Control. Release 24 1993 119 132
48. J.M. Coburn, and D.L. Kaplan Engineering biomaterial-drug conjugates for local and sustained chemotherapeutic delivery Bioconjug. Chem. 26 2015 1212 1223
49. X.Y. Tan, B.B. Li, X.G. Lu, F. Jia, C. Santori, P. Menon, H. Li, B.H. Zhang, J.J. Zhao, and K. Zhang Light-triggered, Self-Immolative Nucleic Acid-Drug Nanostructures J. Am. Chem. Soc. 137 2015 6112 6115
50. E.M. Pelegri-O'Day, E.W. Lin, and H.D. Maynard Therapeutic protein-polymer conjugates: advancing beyond PEGylation J. Am. Chem. Soc. 136 2014 14323 14332
51. J.A. Flygare, T.H. Pillow, and P. Aristoff Antibody-drug conjugates for the treatment of cancer Chem. Biol. Drug Des. 81 2013 113 121
52. G.S. Kwon, and K. Kataoka Block copolymer micelles as long-circulating drug vehicles Adv. Drug Deliv. Rev. 64 2012 237 245
53. A. Maksimenko, F. Dosio, J. Mougin, A. Ferrero, S. Wack, L.H. Reddy, A.A. Weyn, E. Lepeltier, C. Bourgaux, B. Stella, L. Cattel, and P. Couvreur A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity Proc. Natl. Acad. Sci. U. S. A. 111 2014 E217 E226
54. P. Shi, S. Aluri, Y.A. Lin, M. Shah, M. Edman, J. Dhandhukia, H.G. Cui, and J.A. MacKay Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo J. Control. Release 171 2013 330 338
55. W. Wang, P.G. Sreekumar, V. Valluripalli, P. Shi, J.W. Wang, Y.A. Lin, H.G. Cui, R. Kannan, D.R. Hinton, and J.A. MacKay Protein polymer nanoparticles engineered as chaperones protect against apoptosis in human retinal pigment epithelial cells J. Control. Release 191 2014 4 14
56. L.L.X. Peng, A. Ivetac, A.S. Chaudhari, S. Van, G. Zhao, L. Yu, S.B. Howell, J.A. McCammon, and D.A. Gough Characterization of a clinical polymer-drug conjugate using multiscale modeling Biopolymers 93 2010 936 951
57. W.B. Liechty, D.R. Kryscio, B.V. Slaughter, and N.A. Peppas Polymers for drug delivery systems Annu. Rev. Chem. Biomol. Eng. 1 2010 149 173
58. E.G. Kelley, J.N.L. Albert, M.O. Sullivan, and T.H. Epps Stimuli-responsive copolymer solution and surface assemblies for biomedical applications Chem. Soc. Rev. 42 2013 7057 7071
59. L.L. Lock, M. LaComb, K. Schwarz, A.G. Cheetham, Y.A. Lin, P.C. Zhang, and H.G. Cui Self-assembly of natural and synthetic drug amphiphiles into discrete supramolecular nanostructures Faraday Discuss. 166 2013 285 301
60. H.G. Cui, M.J. Webber, and S.I. Stupp Self-assembly of peptide amphiphiles: from molecules to nanostructures to biomaterials Biopolymers 94 2010 1 18
61. J.D. Hartgerink, E. Beniash, and S.I. Stupp Self-assembly and mineralization of peptide-amphiphile nanofibers Science 294 2001 1684 1688
62. T. Aida, E.W. Meijer, and S.I. Stupp Functional supramolecular polymers Science 335 2012 813 817
63. S.I. Stupp, R.H. Zha, L.C. Palmer, H.G. Cui, and R. Bitton Self-assembly of biomolecular soft matter Faraday Discuss. 166 2013 9 30
64. D.E. Discher, and A. Eisenberg Polymer vesicles Science 297 2002 967 973
65. J.M. Barichello, M. Morishita, K. Takayama, and T. Nagai Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method Drug Dev. Ind. Pharm. 25 1999 471 476
66. U. Bilati, E. Allemann, and E. Doelker Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles Eur. J. Pharm. Sci. 24 2005 67 75
67. T. Govender, S. Stolnik, M.C. Garnett, L. Illum, and S.S. Davis PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug J. Control. Release 57 1999 171 185
68. B. Leader, Q.J. Baca, and D.E. Golan Protein therapeutics: a summary and pharmacological classification Nat. Rev. Drug Discov. 7 2008 21 39
69. R. Duncan Polymer conjugates as anticancer nanomedicines Nat. Rev. Cancer 6 2006 688 701
70. R. Tong, and J.J. Cheng Anticancer polymeric nanomedicines Polym. Rev. 47 2007 345 381
71. R. Duncan The dawning era of polymer therapeutics Nat. Rev. Drug Discov. 2 2003 347 360
72. A. Abuchowski, T. Vanes, N.C. Palczuk, and F.F. Davis Alteration of immunological properties of bovine serum-albumin by covalent attachment of polyethylene-glycol J. Biol. Chem. 252 1977 3578 3581
73. N. Larson, and H. Ghandehari Polymeric conjugates for drug delivery Chem. Mater. 24 2012 840 853
74. S.N.S. Alconcel, A.S. Baas, and H.D. Maynard FDA-approved poly(ethylene glycol)-protein conjugate drugs Polym. Chem. (UK) 2 2011 1442 1448
75. D. Peer, J.M. Karp, S. Hong, O.C. FaroKHzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760
76. D. Pfister, and M. Morbidelli Process for protein PEGylation J. Control. Release 180 2014 134 149
77. J.M. Lambert Drug-conjugated monoclonal antibodies for the treatment of cancer Curr. Opin. Pharmacol. 5 2005 543 549
78. A. Beck, T. Wurch, C. Bailly, and N. Corvaia Strategies and challenges for the next generation of therapeutic antibodies Nat. Rev. Immunol. 10 2010 345 352
79. S. Panowski, S. Bhakta, H. Raab, P. Polakis, and J.R. Junutula Site-specific antibody drug conjugates for cancer therapy MAbs 6 2014 34 45
80. P. Agarwal, and C.R. Bertozzi Site-specific antibody-drug conjugates: the nexus of biciorthogonal chemistry, protein engineering, and drug development Bioconjug. Chem. 26 2015 176 192
81. R.M. Broyer, G.N. Grover, and H.D. Maynard Emerging synthetic approaches for protein-polymer conjugations Chem. Commun. 47 2011 2212 2226
82. G.N. Grover, and H.D. Maynard Protein-polymer conjugates: synthetic approaches by controlled radical polymerizations and interesting applications Curr. Opin. Chem. Biol. 14 2010 818 827
83. J.M. Hannink, J.J.L.M. Cornelissen, J.A. Farrera, P. Foubert, F.C. De Schryver, N.A.J.M. Sommerdijk, and R.J.M. Nolte Protein-polymer hybrid amphiphiles Angew. Chem. Int. Ed. 40 2001 4732 4734
84. L.A. Lee, Z.W. Niu, and Q. Wang Viruses and virus-like protein assemblies-chemically programmable nanoscale building blocks Nano Res. 2 2009 349 364
85. N.M. Matsumoto, P. Prabhakaran, L.H. Rome, and H.D. Maynard Smart vaults: thermally-responsive protein nanocapsules ACS Nano 7 2013 867 874
86. P. Thordarson, B. Le Droumaguet, and K. Velonia Well-defined protein-polymer conjugates-synthesis and potential applications Appl. Microbiol. Biotechnol. 73 2006 243 254
87. P. van Rijn Polymer directed protein assemblies Polymers (Basel) 5 2013 576 599
88. M.J. Boerakker, J.M. Hannink, P.H.H. Bomans, P.M. Frederik, R.J.M. Nolte, E.M. Meijer, and N.A.J.M. Sommerdijk Giant amphiphiles by cofactor reconstitution Angew. Chem. Int. Ed. 41 2002 4239 4241
89. M.J. Boerakker, N.E. Botterhuis, P.H.H. Bomans, P.M. Frederik, E.M. Meijer, R.J.M. Nolte, and N.A.J.M. Sommerdijk Aggregation behavior of giant amphiphiles prepared by cofactor reconstitution Chem. Eur. J. 12 2006 6071 6080
90. I.C. Reynhout, J.J.L.M. Cornelissen, and R.J.M. Nolte Self-assembled architectures from biohybrid triblock copolymers J. Am. Chem. Soc. 129 2007 2327 2332
91. K. Velonia, A.E. Rowan, and R.J.M. Nolte Lipase polystyrene giant amphiphiles J. Am. Chem. Soc. 124 2002 4224 4225
92. A.J. Dirks, R.J.M. Nolte, and J.J.L.M. Cornelissen Protein-polymer hybrid amphiphiles Adv. Mater. 20 2008 3953 3957
93. C. Lavigueur, J.G. Garcia, L. Hendriks, R. Hoogenboom, J.J.L.M. Cornelissen, and R.J.M. Nolte Thermoresponsive giant biohybrid amphiphiles Polym. Chem. (UK) 2 2011 333 340
94. K. Velonia Protein-polymer amphiphilic chimeras: recent advances and future challenges Polym. Chem. (UK) 1 2010 944 952
95. B. Le Droumaguet, and K. Velonia In situ ATRP-mediated hierarchical formation of giant amphiphile bionanoreactors Angew. Chem. Int. Ed. 47 2008 6263 6266
96. S.R. Aluri, P. Shi, J.A. Gustafson, W. Wang, Y.A. Lin, H.G. Cui, S.L. Liu, P.S. Conti, Z.B. Li, P.S. Hu, A.L. Epstein, and J.A. MacKay A hybrid protein - polymer nanoworm potentiates apoptosis better than a monoclonal antibody ACS Nano 8 2014 2064 2076
97. S.M. Janib, M.F. Pastuszka, S. Aluri, Z. Folchman-Wagner, P.Y. Hsueh, P. Shi, Y.A. Lin, H. Cui, and J.A. MacKay A quantitative recipe for engineering protein polymer nanoparticles Polym. Chem. (UK) 5 2014 1614 1625
98. C.D. Conover, R.B. Greenwald, A. Pendri, C.W. Gilbert, and K.L. Shum Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker Cancer Chemother. Pharmacol. 42 1998 407 414
99. J. Kopecek, P. Kopeckova, T. Minko, and Z.R. Lu HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action Eur. J. Pharm. Biopharm. 50 2000 61 81
100. J.W. Singer, R. Bhatt, J. Tulinsky, K.R. Buhler, E. Heasley, P. Klein, and P. de Vries Water-soluble poly-(L-glutamic acid)-Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo J. Control. Release 74 2001 243 247
101. Y. Yu, C.K. Chen, W.C. Law, J. Mok, J. Zou, P.N. Prasad, and C. Cheng Well-defined degradable brush polymer-drug conjugates for sustained delivery of paclitaxel Mol. Pharm. 10 2013 867 874
102. J. Khandare, and T. Minko Polymer-drug conjugates: progress in polymeric prodrugs Prog. Polym. Sci. 31 2006 359 397
103. M. Yokoyama, G.S. Kwon, T. Okano, Y. Sakurai, T. Seto, and K. Kataoka Preparation of micelle-forming polymer drug conjugates Bioconjug. Chem. 3 1992 295 301
104. M. Yokoyama, M. Miyauchi, N. Yamada, T. Okano, Y. Sakurai, K. Kataoka, and S. Inoue Polymer micelles as novel drug carrier - Adriamycin-conjugated poly(ethylene glycol) poly(aspartic acid) block copolymer J. Control. Release 11 1990 269 278
105. M. Yokoyama, M. Miyauchi, N. Yamada, T. Okano, Y. Sakurai, K. Kataoka, and S. Inoue Characterization and anticancer activity of the micelle-forming polymeric anticancer drug Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer Cancer Res. 50 1990 1693 1700
106. A. Harada, and K. Kataoka Supramolecular assemblies of block copolymers in aqueous media as nanocontainers relevant to biological applications Prog. Polym. Sci. 31 2006 949 982
107. Y. Bae, N. Nishiyama, S. Fukushima, H. Koyama, M. Yasuhiro, and K. Kataoka Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy Bioconjug. Chem. 16 2005 122 130
108. M. Yokoyama, S. Fukushima, R. Uehara, K. Okamoto, K. Kataoka, Y. Sakurai, and T. Okano Characterization of physical entrapment and chemical conjugation of Adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor J. Control. Release 50 1998 79 92
109. M. Yokoyama, T. Okano, Y. Sakurai, and K. Kataoka Improved synthesis of Adriamycin-conjugated poly(ethylene oxide) poly(aspartic acid) block-copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped Adriamycin J. Control. Release 32 1994 269 277
110. A.S. Mikhail, and C. Allen Poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles containing chemically conjugated and physically entrapped docetaxel: synthesis, characterization, and the influence of the drug on micelle morphology Biomacromolecules 11 2010 1273 1280
111. A. Li, H.P. Luehmann, G.R. Sun, S. Samarajeewa, J. Zou, S.Y. Zhang, F.W. Zhang, M.J. Welch, Y.J. Liu, and K.L. Wooley Synthesis and in vivo pharmacokinetic evaluation of degradable shell cross-linked polymer nanoparticles with poly(carboxybetaine) versus poly(ethylene glycol) surface-grafted coatings ACS Nano 6 2012 8970 8982
112. S. Samarajeewa, R. Shrestha, M. Elsabahy, A. Karwa, A. Li, R.P. Zentay, J.G. Kostelc, R.B. Dorshow, and K.L. Wooley In vitro efficacy of paclitaxel-loaded dual-responsive shell cross-linked polymer nanoparticles having orthogonally degradable disulfide cross-linked corona and polyester core domains Mol. Pharm. 10 2013 1092 1099
113. F.W. Zhang, M. Elsabahy, S.Y. Zhang, L.Y. Lin, J. Zou, and K.L. Wooley Shell crosslinked knedel-like nanoparticles for delivery of cisplatin: effects of crosslinking Nanoscale 5 2013 3220 3225
114. M. Elsabahy, and K.L. Wooley Design of polymeric nanoparticles for biomedical delivery applications Chem. Soc. Rev. 41 2012 2545 2561
115. S.Y. Zhang, J. Zou, M. Elsabahy, A. Karwa, A. Li, D.A. Moore, R.B. Dorshow, and K.L. Wooley Poly(ethylene oxide)-block-polyphosphester-based paclitaxel conjugates as a platform for ultra-high paclitaxel-loaded multifunctional nanoparticles Chem. Sci. 4 2013 2122 2126
116. J. Zou, F.W. Zhang, S.Y. Zhang, S.F. Pollack, M. Elsabahy, J.W. Fan, and K.L. Wooley Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery Adv. Healthc. Mater. 3 2014 441 448
117. D.J. Pochan, Z.Y. Chen, H.G. Cui, K. Hales, K. Qi, and K.L. Wooley Toroidal triblock copolymer assemblies Science 306 2004 94 97
118. Z. Wang, Y.W. Li, X.H. Dong, X.F. Yu, K. Guo, H. Su, K. Yue, C. Wesdemiotis, S.Z.D. Cheng, and W.B. Zhang Giant Gemini surfactants based on polystyrene-hydrophilic polyhedral oligomeric silsesquioxane shape amphiphiles: sequential "click" chemistry and solution self-assembly Chem. Sci. 4 2013 1345 1352
119. L.F. Zhang, and A. Eisenberg Multiple morphologies of crew-cut aggregates of polystyrene-B-poly(acrylic acid) block-copolymers Science 268 1995 1728 1731
120. Z.X. Zhou, X.P. Ma, E.L. Jin, J.B. Tang, M.H. Sui, Y.Q. Shen, E.A. Van Kirk, W.J. Murdoch, and M. Radosz Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery Biomaterials 34 2013 5722 5735
121. A. Marsh, A. Khan, D.M. Haddleton, and M.J. Hannon Atom transfer polymerization: use of uridine and adenosine derivatized monomers and initiators Macromolecules 32 1999 8725 8731
122. X.J. Chen, S. McRae, S. Parelkar, and T. Emrick Polymeric phosphorylcholine-camptothecin conjugates prepared by controlled free radical polymerization and click chemistry Bioconjug. Chem. 20 2009 2331 2341
123. S. Harrisson, J. Nicolas, A. Maksimenko, D.T. Bui, J. Mougin, and P. Couvreur Nanoparticles with in vivo anticancer activity from polymer prodrug amphiphiles prepared by living radical polymerization Angew. Chem. Int. Ed. 52 2013 1678 1682
124. A. Maksimenko, D.T. Bui, D. Desmaele, P. Couvreur, and J. Nicolas Significant tumor growth inhibition from naturally occurring lipid-containing polymer prodrug nanoparticles obtained by the drug-initiated method Chem. Mater. 26 2014 3606 3609
125. R. Tong, L. Tang, L. Ma, C.L. Tu, R. Baumgartner, and J.J. Cheng Smart chemistry in polymeric nanomedicine Chem. Soc. Rev. 43 2014 6982 7012
126. R. Tong, N.P. Gabrielson, T.M. Fan, and J.J. Cheng Polymeric nanomedicines based on poly(lactide) and poly(lactide-co-glycolide) Curr. Opin. Solid State Mater. Sci. 16 2012 323 332
127. R. Tong, and J.J. Cheng Paclitaxel-initiated, controlled polymerization of lactide for the formulation of polymeric nanoparticulate delivery vehicles Angew. Chem. Int. Ed. 47 2008 4830 4834
128. R. Tong, and J.J. Cheng Ring-opening polymerization-mediated controlled formulation of polylactide-drug nanoparticles J. Am. Chem. Soc. 131 2009 4744 4754
129. S.R. MacEwan, and A. Chilkoti Elastin-like polypeptides: biomedical applications of tunable biopolymers Biopolymers 94 2010 60 77
130. A. Chilkoti, M.R. Dreher, and D.E. Meyer Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery Adv. Drug Deliv. Rev. 54 2002 1093 1111
131. J. Bhattacharyya, J.J. Bellucci, I. Weitzhandler, J.R. McDaniel, I. Spasojevic, X.H. Li, C.C. Lin, J.T.A. Chi, and A. Chilkoti A Paclitaxel-Loaded Recombinant Polypeptide Nanoparticle Outperforms Abraxane in Multiple Murine Cancer Models Nat. Commun. 6 2015 10.1038/ncomms8939
132. D.E. Meyer, G.A. Kong, M.W. Dewhirst, M.R. Zalutsky, and A. Chilkoti Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia Cancer Res. 61 2001 1548 1554
133. M.R. Dreher, D. Raucher, N. Balu, O.M. Colvin, S.M. Ludeman, and A. Chilkoti Evaluation of an elastin-like polypeptide-doxorubicin conjugate for cancer therapy J. Control. Release 91 2003 31 43
134. D.Y. Furgeson, M.R. Dreher, and A. Chilkoti Structural optimization of a "smart" doxorubicin-polypeptide conjugate for thermally targeted delivery to solid tumors J. Control. Release 110 2006 362 369
135. A. Chilkoti, T. Christensen, and J.A. MacKay Stimulus responsive elastin biopolymers: applications in medicine and biotechnology Curr. Opin. Chem. Biol. 10 2006 652 657
136. J.R. McDaniel, J. Bhattacharyya, K.B. Vargo, W. Hassouneh, D.A. Hammer, and A. Chilkoti Self-assembly of thermally responsive nanoparticles of a genetically encoded peptide polymer by drug conjugation Angew. Chem. Int. Ed. 52 2013 1683 1687
137. J.R. McDaniel, S.R. MacEwan, X.H. Li, D.C. Radford, C.D. Landon, M. Dewhirst, and A. Chilkoti Rational design of "heat seeking" drug loaded polypeptide nanoparticles that thermally target solid tumors Nano Lett. 14 2014 2890 2895
138. M.C. Eric, M. Mastria, J.R. Mc Daniel, X.X. Li, J. Hyun, M.W. Dewhirst, and A.A. Chilkoti Doxorubicin-conjugated polypeptide nanoparticles inhibit metastasis in two murine models of carcinoma J. Control. Release 208 2015 52 58
139. J.Y. Liu, W.E. Liu, I. Weitzhandler, J. Bhattacharyya, X.H. Li, J. Wang, Y.Z. Qi, S. Bhattacharjee, and A. Chilkoti Ring-opening polymerization of prodrugs: a versatile approach to prepare well-defined drug-loaded nanoparticles Angew. Chem. Int. Ed. 54 2015 1002 1006
140. K. Ulbrich, V. Subr, J. Strohalm, D. Plocova, M. Jelinkova, and B. Rihova Polymeric drugs based on conjugates of synthetic and natural macromolecules I. Synthesis and physico-chemical characterisation J. Control. Release 64 2000 63 79
141. K. Ulbrich, and V. Subr Polymeric anticancer drugs with pH-controlled activation Adv. Drug Deliv. Rev. 56 2004 1023 1050
142. R. Rosario-Melendez, C.L. Harris, R. Delgado-Rivera, L. Yu, and K.E. Uhrich PolyMorphine: an innovative biodegradable polymer drug for extended pain relief J. Control. Release 162 2012 538 544
143. M.A. Ouimet, J. Griffin, A.L. Carbone-Howell, W.H. Wu, N.D. Stebbins, R. Di, and K.E. Uhrich Biodegradable ferulic acid-containing poly(anhydride-ester): degradation products with controlled release and sustained antioxidant activity Biomacromolecules 14 2013 854 861
144. R. Rosario-Melendez, W.L. Yu, and K.E. Uhrich Biodegradable polyesters containing ibuprofen and naproxen as pendant groups Biomacromolecules 14 2013 3542 3548
145. N. Wang, Z.C. Chen, D. Lu, and M.F. Lin Controllable selective synthesis of a polymerizable prodrug of cytarabine by enzymatic and chemical methods Bioorg. Med. Chem. Lett. 15 2005 4064 4067
146. X. Li, Q. Wu, D.S. Lv, and X.F. Lin Controllable synthesis of polymerizable ester and amide prodrugs of acyclovir by enzyme in organic solvent Bioorg. Med. Chem. 14 2006 3377 3382
147. Y. Ding, W.L. Chen, J.H. Hu, M. Du, and D. Yang Polymerizable disulfide paclitaxel prodrug for controlled drug delivery Mater. Sci. Eng. C Mater. 44 2014 386 390
148. X.L. Hu, J.M. Hu, J. Tian, Z.S. Ge, G.Y. Zhang, K.F. Luo, and S.Y. Liu Polyprodrug amphiphiles: hierarchical assemblies for shape-regulated cellular internalization, trafficking, and drug delivery J. Am. Chem. Soc. 135 2013 17617 17629
149. J.A. Johnson, Y.Y. Lu, A.O. Burts, Y. Xia, A.C. Durrell, D.A. Tirrell, and R.H. Grubbs Drug-loaded, Bivalent-Bottle-Brush Polymers by Graft-through ROMP Macromolecules 43 2010 10326 10335
150. L.Y. Liao, J. Liu, E.C. Dreaden, S.W. Morton, K.E. Shopsowitz, P.T. Hammond, and J.A. Johnson A convergent synthetic platform for single-nanoparticle combination cancer therapy: ratiometric loading and controlled release of cisplatin, doxorubicin, and camptothecin J. Am. Chem. Soc. 136 2014 5896 5899
151. A.X. Gao, L.Y. Liao, and J.A. Johnson Synthesis of acid-labile PEG and PEG-doxorubicin-conjugate nanoparticles via brush-first ROMP ACS Macro Lett. 3 2014 854 857
152. R. Mahato, W.Y. Tai, and K. Cheng Prodrugs for improving tumor targetability and efficiency Adv. Drug Deliv. Rev. 63 2011 659 670
153. K.M. Huttunen, H. Raunio, and J. Rautio Prodrugs-from serendipity to rational design Pharmacol. Rev. 63 2011 750 771
154. Y. Singh, M. Palombo, and P.J. Sinko Recent trends in targeted anticancer prodrug and conjugate design Curr. Med. Chem. 15 2008 1802 1826
155. E. Lepeltier, C. Bourgaux, V. Rosilio, J.H. Poupaert, F. Meneau, F. Zouhiri, S. Lepetre-Mouelhi, D. Desmaele, and P. Couvreur Self-assembly of squalene-based nucleolipids: relating the chemical structure of the bioconjugates to the architecture of the nanoparticles Langmuir 29 2013 14795 14803
156. P. Couvreur, B. Stella, L.H. Reddy, H. Hillaireau, C. Dubernet, D. Desmaele, S. Lepetre-Mouelhi, F. Rocco, N. Dereuddre-Bosquet, P. Clayette, V. Rosilio, V. Marsaud, J.M. Renoir, and L. Cattel Squalenoyl nanomedicines as potential therapeutics Nano Lett. 6 2006 2544 2548
157. F. Dosio, L.H. Reddy, A. Ferrero, B. Stella, L. Cattel, and P. Couvreur Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation Bioconjug. Chem. 21 2010 1349 1361
158. N. Semiramoth, C. Di Meo, F. Zouhiri, F. Said-Hassane, S. Valetti, R. Gorges, V. Nicolas, J.H. Poupaert, S. Chollet-Martin, D. Desmaele, R. Gref, and P. Couvreur Self-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infections ACS Nano 6 2012 3820 3831
159. J.L. Arias, L.H. Reddy, M. Othman, B. Gillet, D. Desmaele, F. Zouhiri, F. Dosio, R. Gref, and P. Couvreur Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics ACS Nano 5 2011 1513 1521
160. L. Bildstein, V. Marsaud, H. Chacun, S. Lepetre-Mouelhi, D. Desmaele, P. Couvreur, and C. Dubernet Extracellular-protein-enhanced cellular uptake of squalenoyl gemcitabine from nanoassemblies Soft Matter 6 2010 5570 5580
161. L.H. Reddy, H. Khoury, A. Paci, A. Deroussent, H. Ferreira, C. Dubernet, X. Decleves, M. Besnard, H. Chacun, S. Lepetre-Mouelhi, D. Desmaele, B. Rousseau, C. Laugier, J.C. Cintrat, G. Vassal, and P. Couvreur Squalenoylation favorably modifies the in vivo pharmacokinetics and biodistribution of gemcitabine in mice Drug Metab. Dispos. 36 2008 1570 1577
162. Y.Q. Shen, E.L. Jin, B. Zhang, C.J. Murphy, M.H. Sui, J. Zhao, J.Q. Wang, J.B. Tang, M.H. Fan, E. Van Kirk, and W.J. Murdoch Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery J. Am. Chem. Soc. 132 2010 4259 4265
163. P. Huang, D.L. Wang, Y. Su, W. Huang, Y.F. Zhou, D.X. Cui, X.Y. Zhu, and D.Y. Yan Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-Drug conjugate for cancer Therapy J. Am. Chem. Soc. 136 2014 11748 11756
164. M.C. Branco, and J.P. Schneider Self-assembling materials for therapeutic delivery Acta Biomater. 5 2009 817 831
165. R.S. Tu, and M. Tirrell Bottom-up design of biomimetic assemblies Adv. Drug Deliv. Rev. 56 2004 1537 1563
166. H.M. Wang, Z.M. Yang, and D.J. Adams Controlling peptide-based hydrogelation Mater. Today 15 2012 500 507
167. L.A. Estroff, and A.D. Hamilton Water gelation by small organic molecules Chem. Rev. 104 2004 1201 1217
168. E.A. Appel, J. del Barrio, X.J. Loh, and O.A. Scherman Supramolecular polymeric hydrogels Chem. Soc. Rev. 41 2012 6195 6214
169. X.W. Du, J. Zhou, and B. Xu Supramolecular hydrogels made of basic biological building blocks Chem. Asian. J. 9 2014 1446 1472
170. A.S. Weingarten, R.V. Kazantsev, L.C. Palmer, M. McClendon, A.R. Koltonow, A.P.S. Samuel, D.J. Kiebala, M.R. Wasielewski, and S.I. Stupp Self-assembling hydrogel scaffolds for photocatalytic hydrogen production Nat. Chem. 6 2014 964 970
171. L. Haines-Butterick, K. Rajagopal, M. Branco, D. Salick, R. Rughani, M. Pilarz, M.S. Lamm, D.J. Pochan, and J.P. Schneider Controlling hydrogelation kinetics by peptide design for three-dimensional encapsulation and injectable delivery of cells Proc. Natl. Acad. Sci. U. S. A. 104 2007 7791 7796
172. F. Zhao, M.L. Ma, and B. Xu Molecular hydrogels of therapeutic agents Chem. Soc. Rev. 38 2009 883 891
173. P.K. Vemula, N. Wiradharma, J.A. Ankrum, O.R. Miranda, G. John, and J.M. Karp Prodrugs as self-assembled hydrogels: a new paradigm for biomaterials Curr. Opin. Biotechnol. 24 2013 1174 1182
174. P.K. Vemula, J. Li, and G. John Enzyme catalysis: tool to make and break amygdalin hydrogelators from renewable resources: a delivery model for hydrophobic drugs J. Am. Chem. Soc. 128 2006 8932 8938
175. P.K. Vemula, G.A. Cruikshank, J.M. Karp, and G. John Self-assembled prodrugs: an enzymatically triggered drug-delivery platform Biomaterials 30 2009 383 393
176. B.G. Xing, C.W. Yu, K.H. Chow, P.L. Ho, D.G. Fu, and B. Xu Hydrophobic interaction and hydrogen bonding cooperatively confer a vancomycin hydrogel: a potential candidate for biomaterials J. Am. Chem. Soc. 124 2002 14846 14847
177. Y. Gao, Y. Kuang, Z.F. Guo, Z.H. Guo, I.J. Krauss, and B. Xu Enzyme-instructed molecular self-assembly confers nanofibers and a supramolecular hydrogel of taxol derivative J. Am. Chem. Soc. 131 2009 13576 13577
178. X.M. Li, J.Y. Li, Y.A. Gao, Y. Kuang, J.F. Shi, and B. Xu Molecular nanofibers of olsalazine form supramolecular hydrogels for reductive release of an anti-inflammatory agent J. Am. Chem. Soc. 132 2010 17707 17709
179. J.Y. Li, Y. Kuang, Y. Gao, X.W. Du, J.F. Shi, and B. Xu D-amino acids boost the selectivity and confer supramolecular hydrogels of a nonsteroidal anti-inflammatory drug (NSAID) J. Am. Chem. Soc. 135 2013 542 545
180. C.B. Yang, M.J. Bian, and Z.M. Yang A polymer additive boosts the anti-cancer efficacy of supramolecular nanofibers of taxol Biomater. Sci. (UK) 2 2014 651 654
181. J. Majumder, M.R. Das, J. Deb, S.S. Jana, and P. Dastidar Beta-amino acid and amino-alcohol conjugation of a nonsteroidal anti-Inflammatory drug (NSAID) imparts hydrogelation displaying remarkable biostability, biocompatibility, and anti-inflammatory properties Langmuir 29 2013 10254 10263
182. X.Y. Li, C.B. Yang, Z.L. Zhang, Z.D. Wu, Y. Deng, G.L. Liang, Z.M. Yang, and H. Chen Folic acid as a versatile motif to construct molecular hydrogelators through conjugations with hydrophobic therapeutic agents J. Mater. Chem. 22 2012 21838 21840
183. Z.P. Chen, P.C. Zhang, A.G. Cheetham, J.H. Moon, J.W. Moxley, Y.A. Lin, and H.G. Cui Controlled release of free doxorubicin from peptide-drug conjugates by drug loading J. Control. Release 191 2014 123 130
184. L.L. Lock, Z. Tang, D. Keith, C. Reyes, and H.G. Cui Enzyme-specific doxorubicin drug beacon as drug-resistant theranostic molecular probes ACS Macro Lett. 4 2015 552 555
185. P.C. Zhang, L.L. Lock, A.G. Cheetham, and H.G. Cui Enhanced cellular entry and efficacy of Tat conjugates by rational design of the auxiliary segment Mol. Pharm. 11 2014 964 973
186. R. Lin, A.G. Cheetham, P.C. Zhang, Y.A. Lin, and H.G. Cui Supramolecular filaments containing a fixed 41% paclitaxel loading Chem. Commun. 49 2013 4968 4970
187. A.G. Cheetham, P. Zhang, Y.A. Lin, R. Lin, and H. Cui Synthesis and self-assembly of a mikto-arm star dual drug amphiphile containing both paclitaxel and camptothecin J. Mater. Chem. B 2 2014 7316 7326
188. Y.A. Lin, A.G. Cheetham, P.C. Zhang, Y.C. Ou, Y.G. Li, G.S. Liu, D. Hermida-Merino, I.W. Hamley, and H.G. Cui Multiwalled nanotubes formed by catanionic mixtures of drug amphiphiles ACS Nano 8 2014 12690 12700
189. A.G. Cheetham, Y.C. Ou, P.C. Zhang, and H.G. Cui Linker-determined drug release mechanism of free camptothecin from self-assembling drug amphiphiles Chem. Commun. 50 2014 6039 6042